Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Essence (BIOE) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Bio Essence (BIOE) over the last 6 years, with Q3 2025 value amounting to 16.81.

  • Bio Essence's Equity Ratio fell 30915.36% to 16.81 in Q3 2025 from the same period last year, while for Sep 2025 it was 16.81, marking a year-over-year decrease of 30915.36%. This contributed to the annual value of 10.57 for FY2024, which is 165541.8% down from last year.
  • Latest data reveals that Bio Essence reported Equity Ratio of 16.81 as of Q3 2025, which was down 30915.36% from 27.64 recorded in Q2 2025.
  • Over the past 5 years, Bio Essence's Equity Ratio peaked at 0.6 during Q4 2023, and registered a low of 27.64 during Q2 2025.
  • For the 5-year period, Bio Essence's Equity Ratio averaged around 4.52, with its median value being 1.5 (2022).
  • Its Equity Ratio has fluctuated over the past 5 years, first skyrocketed by 7123.52% in 2023, then tumbled by 322532.72% in 2025.
  • Quarter analysis of 5 years shows Bio Essence's Equity Ratio stood at 1.43 in 2021, then plummeted by 46.39% to 2.09 in 2022, then skyrocketed by 71.24% to 0.6 in 2023, then tumbled by 1655.42% to 10.57 in 2024, then plummeted by 59.1% to 16.81 in 2025.
  • Its Equity Ratio stands at 16.81 for Q3 2025, versus 27.64 for Q2 2025 and 8.68 for Q1 2025.